Mode
Text Size
Log in / Sign up

Preclinical study characterizes SARS-CoV-2 particles in infected cells and patient nasal swabs using flow virometryLab study finds new way to detect SARS-CoV-2 particles in patient samples

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that SARS-CoV-2 particles were detected in PCR-confirmed patient nasal swabs without prior purification steps.

This preclinical research article focuses on the detection and characterization of single SARS-CoV-2 viral particles. The investigation utilized flow virometry, sample inactivation using temperature or detergent, antibodies and dyes for lipid membranes and nucleic acids, and electron microscopy. The setting was a laboratory environment.

The authors observed particles measuring 70-100 nm in supernatants of infected cells. Particle appearance was associated to the increase in viral RNA and infectivity. The study also examined particle size, viral RNA levels, infectivity, spike protein detection, lipid envelope detection, RNA genome detection, and spike conformation changes.

SARS-CoV-2 particles were detected in PCR-confirmed patient nasal swabs without prior purification steps. The disappearance of particles occurred after sample inactivation using temperature or detergent. Spike detection in particles outcompetes particle concentration to predict infectivity. Safety data, adverse events, and discontinuations were not reported. The study population included virus infected cells and PCR-confirmed patient nasal swabs. Sample size was not reported. Follow-up duration was not reported. Funding or conflicts were not reported.

Scientists in a laboratory setting tested a new method to find SARS-CoV-2 virus particles. They used flow virometry along with temperature, detergent, antibodies, and dyes to examine virus samples. The team also looked at particle size, viral RNA levels, and infectivity. They studied supernatants from virus-infected cells and nasal swabs from patients confirmed to have the virus via PCR testing.

The researchers found virus particles measuring 70 to 100 nanometers in the infected cell samples. They noted that the appearance of these particles was associated with higher viral RNA levels and infectivity. When they treated samples with heat or detergent, the particles disappeared. The study also found that detecting the spike protein on the virus particles was a strong predictor of infectivity.

Importantly, the team detected SARS-CoV-2 particles directly in patient nasal swabs without needing to purify the samples first. This was done using standard lab techniques. Because this was a preclinical study performed in a laboratory, the results have not yet been tested in large groups of people. The study did not report any safety concerns because no human treatments were involved. Readers should understand that these findings are early and come from a small lab setting.

What this means for you:
Lab study detects SARS-CoV-2 in swabs without purification; results are early and from a lab setting.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Virus infected cells release viral particles, which have variable protein content and are functionally diverse. Deciphering this heterogeneity remains a challenge. Here, we adapt flow virometry to detect and phenotype severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles. In supernatants of infected cells, we observe particles measuring 70-100 nm. The appearance of these particles is associated to the increase in viral RNA and infectivity. Sample inactivation using temperature or detergent leads to the disappearance of these particles. Using antibodies and dyes for lipid membranes and nucleic acids, we detect the spike protein, the lipid envelope and the RNA genome. We further confirm the presence of viral particles by electron microscopy. Analyzing different viral preparations demonstrate that spike detection in particles outcompetes particle concentration to predict infectivity. Antibodies against different spike epitopes enable probing of spike conformation changes in the presence of soluble ACE2. Lastly, we detect SARS-CoV-2 particles in PCR-confirmed patient nasal swabs without prior purification steps. In summary, we developed an efficient framework to detect and characterize single SARS-CoV-2 particles.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.